Los Angeles Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Los Angeles Capital Management's TNDM Position: Q2 2026 in Review
Los Angeles Capital Management held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 348 shares worth $5.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2119.
Los Angeles Capital Management first reported a position in TNDM in Q1 2017 and has held it in 19 quarters since. The position peaked at $1.79M in Q1 2020. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Los Angeles Capital Management held 348 shares of Tandem Diabetes Care worth $5.25K as of Q2 2026.
- Los Angeles Capital Management left its Tandem Diabetes Care share count unchanged in Q2 2026.
- Tandem Diabetes Care made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2119 holding.
- Los Angeles Capital Management first reported a position in Tandem Diabetes Care in Q1 2017 and has held it in 19 quarters since.
- Los Angeles Capital Management's Tandem Diabetes Care position peaked at $1.79M in Q1 2020.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.